跳至主要内容
临床试验/NCT01983566
NCT01983566终止1 期

Investigation of the Effect of Food and of Increased Gastric pH on the Relative Bioavailability of Deleobuvir Following Single Oral Administration in Healthy Caucasian and Japanese Subjects (an Open-label, Randomised, Four-way Crossover Study)

Boehringer Ingelheim1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2013年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
终止
入组人数
16
试验地点
1
主要终点
AUC(0-tz)

研究概览

简要总结

The purpose of this trial is to investigate the effect of food with different fat content and of gastric pH increase (mediated by multiple dosing of omeprazole) on the relative bioavailability of deleobuvir.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

BI 207127 fasted

Active Comparator

patient to receive BI 207127 as a single dose in fasted state

干预措施: BI 207127 (Drug)

BI 207127 high fat

Experimental

patient to receive BI 207127 as a single dose after a high fat breakfast

干预措施: BI 207127 high fat (Drug)

BI 207127 low fat

Experimental

patient to receive BI 207127 as a single dose after a low fat breakfast

干预措施: BI 207127 low fat (Drug)

BI 207127 with Omeprazole

Experimental

patient to receive BI 207127 as a single dose after 4 days treatment with Omeprazole 40 mg once a day

干预措施: BI 207127 with Omeprazole (Drug)

结局指标

主要结局

AUC(0-tz)

时间窗: 1 hour (h) before drug administration and 30 minutes (min), 1h, 1h 30min, 2h, 2h 30min, 3h, 4h, 5h, 6h, 8h, 10h, 12h, 24h and 48h after drug administration

Area under the concentration-time curve of deleobuvir in plasma over the time interval from 0 to the last quantifiable data point (AUC0-tz)

Cmax

时间窗: 1 hour (h) before drug administration and 30 minutes (min), 1h, 1h 30min, 2h, 2h 30min, 3h, 4h, 5h, 6h, 8h, 10h, 12h, 24h and 48h after drug administration

Maximum measured concentration of deleobuvir in plasma (Cmax)

次要结局

  • AUC(0-inf)(1 hour (h) before drug administration and 30 minutes (min), 1h, 1h 30min, 2h, 2h 30min, 3h, 4h, 5h, 6h, 8h, 10h, 12h, 24h and 48h after drug administration)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验